Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

NCT04486313 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
935
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Romark Laboratories L.C.